📣 VC round data is live. Check it out!

Alzchem Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for Alzchem Group and similar public comparables like Ingevity, MOPCO, Innospec, Saudi Chemical and more.

Alzchem Group Overview

About Alzchem Group

Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.


Founded

1908

HQ

Germany

Employees

1.7K

Sectors

Financials (LTM)

Revenue: $680M
EBITDA: $143M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Alzchem Group Financials

Alzchem Group reported last 12-month revenue of $680M and EBITDA of $143M.

In the same LTM period, Alzchem Group generated $444M in gross profit, $143M in EBITDA, and $76M in net income.

Revenue (LTM)


Alzchem Group P&L

In the most recent fiscal year, Alzchem Group reported revenue of $663M and EBITDA of $139M.

Alzchem Group is profitable as of last fiscal year, with gross margin of 68%, EBITDA margin of 21%, and net margin of 11%.

See analyst estimates for Alzchem Group
LTMLast FY202320242025202620272028
Revenue$680M$663M$629M$645M$654M
Gross Profit$444M$453M$368M$420M$453M
Gross Margin65%68%59%65%69%
EBITDA$143M$139M$95M$125M$139M
EBITDA Margin21%21%15%19%21%
EBIT Margin16%16%11%14%17%
Net Profit$76M$75M$40M$63M$74M
Net Margin11%11%6%10%11%

Financial data powered by Morningstar, Inc.

Alzchem Group Stock Performance

Alzchem Group has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Alzchem Group's stock price is $217.23.

Alzchem Group share price decreased by 1.5% in the last 30 days, and increased by 36.2% in the last year.

Alzchem Group has an EPS (earnings per share) of $7.42.

See more trading valuation data for Alzchem Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B-1.4%-1.5%8.7%36.2%$7.42

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Alzchem Group Valuation Multiples

Alzchem Group trades at 3.2x EV/Revenue multiple, and 15.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Alzchem Group

EV / Revenue (LTM)


Alzchem Group Financial Valuation Multiples

As of June 3, 2026, Alzchem Group has market cap of $2B and EV of $2B.

Alzchem Group has a P/E ratio of 28.9x.

LTMLast FY202320242025202620272028
EV/Revenue3.2x3.3x3.4x3.4x3.3x
EV/EBITDA15.2x15.5x22.7x17.3x15.5x
EV/EBIT20.0x20.0x32.6x23.8x20.0x
EV/Gross Profit4.9x4.8x5.9x5.2x4.8x
P/E28.9x29.3x54.6x35.0x29.8x
EV/FCF35.9x13.6x25.6x17.7x13.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Alzchem Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Alzchem Group Margins & Growth Rates

Alzchem Group grew revenue by 6% and EBITDA by 8% in the last fiscal year.

In the most recent fiscal year, Alzchem Group reported gross margin of 68%, EBITDA margin of 21%, and net margin of 11%.

See estimated margins and future growth rates for Alzchem Group

Alzchem Group Margins

Last FY202420252026202720282029
Gross Margin68%65%69%66%
EBITDA Margin21%19%21%21%
EBIT Margin16%14%17%16%
Net Margin11%10%11%11%
FCF Margin24%19%24%7%

Alzchem Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth6%3%1%7%
Gross Profit Growth3%14%8%3%
EBITDA Growth8%31%11%8%
EBIT Growth2%37%19%2%
Net Profit Growth3%56%17%5%
FCF Growth(69%)45%30%(69%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Alzchem Group Operational KPIs

Alzchem Group's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Alzchem Group's Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Alzchem Group's Rule of X is 40% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Alzchem Group
LTMLast FY202320242025202620272028
Rule of 4031%29%---
Bessemer Rule of X47%40%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue-3%4%4%3%
G&A Expenses to Revenue-2%2%2%2%
Opex to Revenue-52%48%51%53%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Alzchem Group Competitors

Alzchem Group competitors include Ingevity, MOPCO, Innospec, Saudi Chemical, OQ Base Industries, Abu Qir Fertilizers, Saudi Kayan, Robertet, Teijin and Solvac.

Most Alzchem Group public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Ingevity3.0x3.1x8.8x8.9x
MOPCO4.0x3.2x7.0x5.7x
Innospec1.0x1.0x8.7x8.9x
Saudi Chemical1.2x-15.1x-
OQ Base Industries4.8x4.5x10.9x11.6x
Abu Qir Fertilizers2.8x1.6x6.2x3.2x
Saudi Kayan2.1x2.1x24.7x18.3x
Robertet2.0x2.0x9.9x10.0x

This data is available for Pro users. Sign up to see all Alzchem Group competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Alzchem Group

When was Alzchem Group founded?Alzchem Group was founded in 1908.
Where is Alzchem Group headquartered?Alzchem Group is headquartered in Germany.
How many employees does Alzchem Group have?As of today, Alzchem Group has over 1K employees.
Is Alzchem Group publicly listed?Yes, Alzchem Group is a public company listed on Frankfurt Stock Exchange.
What is the stock symbol of Alzchem Group?Alzchem Group trades under ACT ticker.
When did Alzchem Group go public?Alzchem Group went public in 2011.
Who are competitors of Alzchem Group?Alzchem Group main competitors include Ingevity, MOPCO, Innospec, Saudi Chemical, OQ Base Industries, Abu Qir Fertilizers, Saudi Kayan, Robertet, Teijin, Solvac.
What is the current market cap of Alzchem Group?Alzchem Group's current market cap is $2B.
What is the current revenue of Alzchem Group?Alzchem Group's last 12 months revenue is $680M.
What is the current revenue growth of Alzchem Group?Alzchem Group revenue growth (NTM/LTM) is 10%.
What is the current EV/Revenue multiple of Alzchem Group?Current revenue multiple of Alzchem Group is 3.2x.
What is the current EBITDA of Alzchem Group?Alzchem Group's last 12 months EBITDA is $143M.
What is Alzchem Group's EBITDA margin?Alzchem Group's last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Alzchem Group?Current EBITDA multiple of Alzchem Group is 15.2x.
What is the current FCF of Alzchem Group?Alzchem Group's last 12 months FCF is $60M.
What is Alzchem Group's FCF margin?Alzchem Group's last 12 months FCF margin is 9%.
What is the current EV/FCF multiple of Alzchem Group?Current FCF multiple of Alzchem Group is 35.9x.
How many companies Alzchem Group has acquired to date?Alzchem Group hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Alzchem Group has invested to date?Alzchem Group hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Alzchem Group

Lists including Alzchem Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial